RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities 2) AML with multilineage dysplasia 3) Therapy-related AML 4) AML not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML has been recently reduced from 30% (French-American-British [FAB] classification) to 20% (WHO classification). (WHO, 2001)
View Complete Description Individual Studies |
|
|---|---|
|
|
Authors: Timothy J Ley, Elaine R Mardis, Li Ding, Bob Fulton, Michael D McLellan, Ken Chen, David Dooling, Brian H Dunford-Shore, Sean McGrath, Matthew Hickenbotham,…
Nature 2008 Nov 6Authors: Maria E Figueroa, Sanne Lugthart, Yushan Li, Claudia Erpelinck-Verschueren, Xutao Deng, Paul J Christos, Elizabeth Schifano, James Booth, Wim van Putten, Lucy Skrabanek,…
Cancer cell 2010 Jan 19Thought leaders and organizations working on research involving acute myeloid leukemia.
conditions: Acute Myeloid Leukemia
interventions: Gemtuzumab ozogamicin
conditions: Acute Myeloid Leukemia
interventions: Gemtuzumab Ozogamicin
MD
American University of Beirut Medical Center
Praticien Hospitalier
University Hospital
No NextBio groups were found for “acute myeloid leukemia”.
Be the first to
start
a group and share your interests with others within the NextBio community.